Functional and Structural Characterization of a Novel HLA-DRB1*04:01-Restricted α-Enolase T Cell Epitope in Rheumatoid Arthritis

Antibodies to citrullinated proteins, common in rheumatoid arthritis (RA) patients, are strongly associated to a specific set of HLA-DR alleles including HLA-DRB1*04:01, *04:04, and *01:01. Here, we first demonstrate that autoantibody levels toward the dominant citrullinated B cell epitope from α-en...

Full description

Bibliographic Details
Main Authors: Christina Gerstner, Anatoly Dubnovitsky, Charlotta Sandin, Genadiy Kozhukh, Hannes Uchtenhagen, Eddie A. James, Johan Rönnelid, Anders Jimmy Ytterberg, Jennifer Pieper, Evan Reed, Karolina Tandre, Mary Rieck, Roman A. Zubarev, Lars Rönnblom, Tatyana Sandalova, Jane H. Buckner, Adnane Achour, Vivianne Malmström
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2016.00494/full
id doaj-0896a9add6fe43039b24b4c4429423b1
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Christina Gerstner
Anatoly Dubnovitsky
Anatoly Dubnovitsky
Charlotta Sandin
Genadiy Kozhukh
Genadiy Kozhukh
Hannes Uchtenhagen
Hannes Uchtenhagen
Eddie A. James
Johan Rönnelid
Anders Jimmy Ytterberg
Anders Jimmy Ytterberg
Jennifer Pieper
Evan Reed
Karolina Tandre
Mary Rieck
Roman A. Zubarev
Lars Rönnblom
Tatyana Sandalova
Tatyana Sandalova
Jane H. Buckner
Adnane Achour
Adnane Achour
Vivianne Malmström
spellingShingle Christina Gerstner
Anatoly Dubnovitsky
Anatoly Dubnovitsky
Charlotta Sandin
Genadiy Kozhukh
Genadiy Kozhukh
Hannes Uchtenhagen
Hannes Uchtenhagen
Eddie A. James
Johan Rönnelid
Anders Jimmy Ytterberg
Anders Jimmy Ytterberg
Jennifer Pieper
Evan Reed
Karolina Tandre
Mary Rieck
Roman A. Zubarev
Lars Rönnblom
Tatyana Sandalova
Tatyana Sandalova
Jane H. Buckner
Adnane Achour
Adnane Achour
Vivianne Malmström
Functional and Structural Characterization of a Novel HLA-DRB1*04:01-Restricted α-Enolase T Cell Epitope in Rheumatoid Arthritis
Frontiers in Immunology
rheumatoid arthritis
HLA-DR4/α-enolase
neo-antigen
CD4+ T cell
autoimmunity
cytokines
author_facet Christina Gerstner
Anatoly Dubnovitsky
Anatoly Dubnovitsky
Charlotta Sandin
Genadiy Kozhukh
Genadiy Kozhukh
Hannes Uchtenhagen
Hannes Uchtenhagen
Eddie A. James
Johan Rönnelid
Anders Jimmy Ytterberg
Anders Jimmy Ytterberg
Jennifer Pieper
Evan Reed
Karolina Tandre
Mary Rieck
Roman A. Zubarev
Lars Rönnblom
Tatyana Sandalova
Tatyana Sandalova
Jane H. Buckner
Adnane Achour
Adnane Achour
Vivianne Malmström
author_sort Christina Gerstner
title Functional and Structural Characterization of a Novel HLA-DRB1*04:01-Restricted α-Enolase T Cell Epitope in Rheumatoid Arthritis
title_short Functional and Structural Characterization of a Novel HLA-DRB1*04:01-Restricted α-Enolase T Cell Epitope in Rheumatoid Arthritis
title_full Functional and Structural Characterization of a Novel HLA-DRB1*04:01-Restricted α-Enolase T Cell Epitope in Rheumatoid Arthritis
title_fullStr Functional and Structural Characterization of a Novel HLA-DRB1*04:01-Restricted α-Enolase T Cell Epitope in Rheumatoid Arthritis
title_full_unstemmed Functional and Structural Characterization of a Novel HLA-DRB1*04:01-Restricted α-Enolase T Cell Epitope in Rheumatoid Arthritis
title_sort functional and structural characterization of a novel hla-drb1*04:01-restricted α-enolase t cell epitope in rheumatoid arthritis
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2016-11-01
description Antibodies to citrullinated proteins, common in rheumatoid arthritis (RA) patients, are strongly associated to a specific set of HLA-DR alleles including HLA-DRB1*04:01, *04:04, and *01:01. Here, we first demonstrate that autoantibody levels toward the dominant citrullinated B cell epitope from α-enolase are significantly elevated in HLA-DRB1*04:01-positive RA patients. Furthermore, we identified α-enolase-derived T cell epitopes and demonstrated that native and citrullinated versions of several peptides bind with different affinities to HLA-DRB1*04:01, *04:04, and *01:01. The citrulline residues in the eight identified peptides are distributed throughout the entire length of the presented epitopes and more specifically, localized at peptide positions p-2, p2, p4, p6, p7, p10, and p11. Importantly, in contrast to its native version peptide 26 (TSKGLFRAAVPSGAS), the HLA-DRB1*04:01-restricted citrullinated peptide Cit26 (TSKGLFCitAAVPSGAS) elicited significant functional T cell responses in primary cells from RA patients. Comparative analysis of the crystal structures of HLA-DRB1*04:01 in complex with peptide 26 or Cit26 demonstrated that the posttranslational modification did not alter the conformation of the peptide. And since citrullination is the only structural difference between the two complexes, this indicates that the neo-antigen Cit26 is recognized by T cells with high specificity to the citrulline residue.
topic rheumatoid arthritis
HLA-DR4/α-enolase
neo-antigen
CD4+ T cell
autoimmunity
cytokines
url http://journal.frontiersin.org/article/10.3389/fimmu.2016.00494/full
work_keys_str_mv AT christinagerstner functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
AT anatolydubnovitsky functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
AT anatolydubnovitsky functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
AT charlottasandin functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
AT genadiykozhukh functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
AT genadiykozhukh functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
AT hannesuchtenhagen functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
AT hannesuchtenhagen functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
AT eddieajames functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
AT johanronnelid functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
AT andersjimmyytterberg functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
AT andersjimmyytterberg functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
AT jenniferpieper functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
AT evanreed functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
AT karolinatandre functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
AT maryrieck functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
AT romanazubarev functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
AT larsronnblom functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
AT tatyanasandalova functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
AT tatyanasandalova functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
AT janehbuckner functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
AT adnaneachour functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
AT adnaneachour functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
AT viviannemalmstrom functionalandstructuralcharacterizationofanovelhladrb10401restrictedaenolasetcellepitopeinrheumatoidarthritis
_version_ 1725206296125243392
spelling doaj-0896a9add6fe43039b24b4c4429423b12020-11-25T01:02:10ZengFrontiers Media S.A.Frontiers in Immunology1664-32242016-11-01710.3389/fimmu.2016.00494224418Functional and Structural Characterization of a Novel HLA-DRB1*04:01-Restricted α-Enolase T Cell Epitope in Rheumatoid ArthritisChristina Gerstner0Anatoly Dubnovitsky1Anatoly Dubnovitsky2Charlotta Sandin3Genadiy Kozhukh4Genadiy Kozhukh5Hannes Uchtenhagen6Hannes Uchtenhagen7Eddie A. James8Johan Rönnelid9Anders Jimmy Ytterberg10Anders Jimmy Ytterberg11Jennifer Pieper12Evan Reed13Karolina Tandre14Mary Rieck15Roman A. Zubarev16Lars Rönnblom17Tatyana Sandalova18Tatyana Sandalova19Jane H. Buckner20Adnane Achour21Adnane Achour22Vivianne Malmström23Rheumatology Unit, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, SwedenNeuroimmunology Unit, Department of Clinical Neurosciences, Center for Molecular Medicine, Karolinska Institutet, Stockholm, SwedenScience for Life Laboratory, Department of Medicine Solna, Karolinska Institutet, Stockholm, SwedenRheumatology Unit, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, SwedenRheumatology Unit, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, SwedenScience for Life Laboratory, Department of Medicine Solna, Karolinska Institutet, Stockholm, SwedenRheumatology Unit, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, SwedenTranslational Research program, BRI at Virginia Mason, Seattle, WA, USATetramer Core, BRI at Virginia Mason, Seattle, WA, USADepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, SwedenRheumatology Unit, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, SwedenDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, SwedenRheumatology Unit, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, SwedenRheumatology Unit, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, SwedenScience for Life Laboratory, Department of Medical Sciences, Rheumatology, Uppsala University, Uppsala, SwedenTranslational Research program, BRI at Virginia Mason, Seattle, WA, USADepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, SwedenScience for Life Laboratory, Department of Medical Sciences, Rheumatology, Uppsala University, Uppsala, SwedenScience for Life Laboratory, Department of Medicine Solna, Karolinska Institutet, Stockholm, SwedenDepartment of Infectious Diseases, Karolinska University Hospital Solna, Stockholm, SwedenTranslational Research program, BRI at Virginia Mason, Seattle, WA, USAScience for Life Laboratory, Department of Medicine Solna, Karolinska Institutet, Stockholm, SwedenDepartment of Infectious Diseases, Karolinska University Hospital Solna, Stockholm, SwedenRheumatology Unit, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, SwedenAntibodies to citrullinated proteins, common in rheumatoid arthritis (RA) patients, are strongly associated to a specific set of HLA-DR alleles including HLA-DRB1*04:01, *04:04, and *01:01. Here, we first demonstrate that autoantibody levels toward the dominant citrullinated B cell epitope from α-enolase are significantly elevated in HLA-DRB1*04:01-positive RA patients. Furthermore, we identified α-enolase-derived T cell epitopes and demonstrated that native and citrullinated versions of several peptides bind with different affinities to HLA-DRB1*04:01, *04:04, and *01:01. The citrulline residues in the eight identified peptides are distributed throughout the entire length of the presented epitopes and more specifically, localized at peptide positions p-2, p2, p4, p6, p7, p10, and p11. Importantly, in contrast to its native version peptide 26 (TSKGLFRAAVPSGAS), the HLA-DRB1*04:01-restricted citrullinated peptide Cit26 (TSKGLFCitAAVPSGAS) elicited significant functional T cell responses in primary cells from RA patients. Comparative analysis of the crystal structures of HLA-DRB1*04:01 in complex with peptide 26 or Cit26 demonstrated that the posttranslational modification did not alter the conformation of the peptide. And since citrullination is the only structural difference between the two complexes, this indicates that the neo-antigen Cit26 is recognized by T cells with high specificity to the citrulline residue.http://journal.frontiersin.org/article/10.3389/fimmu.2016.00494/fullrheumatoid arthritisHLA-DR4/α-enolaseneo-antigenCD4+ T cellautoimmunitycytokines